U.S. Transportation Stock News

VNET Group recently announced a US$137.7 million follow-on equity offering at a steep discount and confirmed the past resignation of CFO Qiyu Wang, moves that have raised concerns about shareholder dilution and leadership continuity. The company was also removed from a major investment bank's Asia-Pacific Conviction List, highlighting wavering institutional confidence at a time when its financing choices are under scrutiny. Against this backdrop of discounted equity issuance, we'll now...

Ryerson Holding Corporation recently reported past first-quarter 2026 results, with sales rising to US$1,566.5 million and net income reaching US$4.5 million, alongside a return to positive earnings per share from continuing operations. On the same day, the company also filed a US$50.22 million shelf registration for 1,800,000 common shares tied to an ESOP-related offering, underscoring its use of equity for employee benefit plans. We will now examine how Ryerson’s return to profitability...

Taysha Gene Therapies (TSHA) has reaffirmed FDA alignment on the Biologics License Application pathway for TSHA-102, including pivotal trial design and the potential use of a six month interim analysis for approval. See our latest analysis for Taysha Gene Therapies. The reaffirmed FDA pathway comes after a run in the stock, with a 30 day share price return of 45.95% and a 1 year total shareholder return of 217.62%. This signals strong momentum despite recent earnings losses and ongoing cash...

Liberty Live Holdings, Inc. reported first-quarter 2026 results, with revenue rising to US$63.62 million from US$47.06 million a year earlier, while net loss widened to US$294.14 million from US$29.48 million. This combination of higher sales and a much larger loss highlights how Liberty Live Holdings is balancing growth with the cost of its operations. Next, we’ll examine how the sharp increase in net loss alongside revenue growth shapes Liberty Live Holdings’ broader investment...

The Buckle, Inc. recently reported that for the 4-week period ended May 2, 2026, comparable store net sales edged up 0.2% and total net sales rose to US$86.3 million, while year-to-date 13-week net sales increased to US$288.7 million. An interesting takeaway is that Buckle’s modest monthly comparable growth contrasts with a stronger 5.1% year-to-date comparable sales increase, highlighting resilience across the broader quarter. We’ll now examine how this solid 5.1% year-to-date comparable...

Huntsman Corporation recently reported first-quarter 2026 results showing sales of US$1,420 million and a net loss of US$53 million, while shareholders voted against a proposal for an independent board chair and the company affirmed a quarterly dividend of US$0.0875 per share. These developments, alongside ongoing restructuring and European plant-closure programs discussed in earlier filings, highlight the cost and governance pressures shaping Huntsman’s current operating profile. We’ll now...

TowneBank (TOWN) stock drew attention after recent trading left it modestly higher over the past week, but lower over the past month and over the past three months, prompting closer inspection of its fundamentals. See our latest analysis for TowneBank. At a share price of $34.99, TowneBank has a 1-day share price return of 0.46% and a year to date share price return of 5.33%, while its 3 year total shareholder return of 80.75% points to stronger momentum over the longer term. If TowneBank’s...

If you are wondering whether AGNC Investment at US$10.86 still offers value or if most of the opportunity is already priced in, this article walks through what the numbers are saying about the stock. The share price has returned 2.0% over the past week and 3.7% over the past month, while year to date the stock is down 0.6%. The 1 year and 3 year returns stand at 39.1% and 85.7% respectively, with a 17.5% return over 5 years. Recent coverage has focused on AGNC Investment's position within...

In the past week, Innospec Inc. reported first-quarter 2026 results showing sales of US$453.2 million and net income of US$30.4 million, while also raising its semi-annual dividend by 10% to US$0.92 per share and authorizing a new US$75 million share repurchase program. These moves highlight management’s emphasis on returning cash to shareholders even as operations recover from winter-storm disruptions and segment performance remains mixed. Next, we’ll explore how the higher dividend and...

In April 2026, Box, Inc. announced the general availability of Box Automate, a no-code, AI-powered workflow automation solution built directly into its content platform to orchestrate work across people, AI agents, and enterprise systems. By treating content as the system of record and triggering workflows from document state, metadata, and AI-derived insights, Box is aiming to make unstructured information far more actionable for HR, finance, legal, and other enterprise teams. Next, we’ll...

Generac Holdings Inc. reported past first-quarter 2026 results with sales of US$1,059.37 million and net income of US$73.25 million, alongside higher earnings per share than a year earlier. Alongside these results, management slightly raised its full-year 2026 sales growth outlook while maintaining its expected net income margin range of 8.0% to 9.0%, reinforcing confidence in operational progress. With full-year sales growth guidance raised to the mid-to-high teens, we’ll now examine how...

Host Hotels & Resorts (HST) is in focus after reporting first quarter 2026 results that exceeded profitability expectations, lifted its full year comparable hotel RevPAR guidance, and paired asset sale gains with a special dividend announcement. See our latest analysis for Host Hotels & Resorts. The share price has reacted positively to the first quarter update, with a 1 day share price return of 2.77% and a 7 day share price return of 6.76%. The 1 year total shareholder return of 49.75% and...

ArriVent BioPharma (AVBP) drew fresh attention after announcing FDA clearance of its investigational new drug application for ARR-002, a first-in-class dual-target antibody-drug conjugate for ovarian and endometrial cancers. See our latest analysis for ArriVent BioPharma. Despite a recent dip, with a 1 day share price return down 2.60% and 7 day share price return down 7.20%, ArriVent’s 30 day and year to date share price returns of 14.53% and 38.70%, alongside a 1 year total shareholder...

Tecnoglass Q1 earnings and reaffirmed guidance Tecnoglass (TGLS) reported first quarter 2026 revenue of US$249.01 million compared with US$222.29 million a year earlier, while net income declined to US$31.89 million and earnings per share moved to US$0.71 from US$0.90. Alongside these mixed results, the company reaffirmed full year 2026 revenue guidance of US$1.06b to US$1.13b. This gives investors updated context for assessing how the current trading price lines up with management’s...

USA TODAY (TDAY) stock is in focus after the company returned to profitability in the first quarter of 2026, posting positive net income and reaffirming full year earnings guidance despite lower revenue. See our latest analysis for USA TODAY. The earnings return to profit and reaffirmed 2026 guidance have arrived alongside strong momentum, with a 90 day share price return of 26.96% and a 1 year total shareholder return of 105.66%, suggesting sentiment has strengthened around the earnings...

Rambus recently launched its PCIe 7.0 Switch IP with Time Division Multiplexing, expanding its interconnect portfolio to support bandwidth-intensive AI, cloud, and high-performance computing systems while aiming to improve link utilization and reduce system complexity for large-scale distributed architectures. This new switch IP strengthens Rambus’ position in high-speed interface IP by targeting emerging disaggregated and pooled compute designs that require deterministic, low-latency data...

If you are wondering whether Sonos stock still offers value after a strong run or a rough patch, this article breaks down what the current price might be telling you. Over the past year, the stock has returned 44.4%, compared with a 16.1% gain over the last 30 days, while year to date it is down 13.9% and the 5-year return sits at a 55.5% loss. Recent headlines around Sonos have focused on its role in the consumer audio market and how sentiment has shifted around the stock. These stories...

What Essent Group’s latest quarter means for investors Essent Group (ESNT) just posted first quarter results that topped analyst earnings and revenue expectations, alongside an affirmed US$0.35 quarterly dividend and updates on its growing property & casualty reinsurance platform. See our latest analysis for Essent Group. The earnings beat and reaffirmed dividend have arrived alongside a recent pick up in momentum, with a 1 day share price return of 2.52% and 7 day share price return of...

In early May 2026, Caris Life Sciences reported first-quarter revenue of US$216.17 million versus US$120.92 million a year earlier, with net loss improving to US$0.51 million, while also securing MolDX approval for its Caris ChromoSeq whole genome assay and launching the AI-driven Caris MI Clarity breast cancer prognostic test. Together, these developments highlight Caris’ efforts to broaden its precision oncology portfolio across hematologic malignancies and early-stage breast cancer, while...

Valero Energy (VLO) has just paired a regular quarterly dividend of $1.20 per share with a sharp swing back to profitability in the first quarter, giving investors fresh numbers to reassess the stock. See our latest analysis for Valero Energy. The recent quarterly profit and steady dividend come against a share price of $236.35, with a 90 day share price return of 16.61% and a year to date share price return of 42.97%. The 1 year total shareholder return of 99.87% suggests strong momentum has...

Mondelez International recently reported first-quarter 2026 results, with sales rising to US$10.08 billion and net income increasing to US$560 million, alongside higher basic and diluted earnings per share of US$0.44 from continuing operations. In addition, the company’s chief global inclusion and learning officer is scheduled to speak at the ISG Future Workplace Summit in New York, highlighting how its focus on workforce development and inclusion sits alongside its improving financial...

In the past week, BeOne Medicines AG reported first-quarter 2026 results with revenue of US$1,513.44 million and net income of US$227.36 million, raised its full-year 2026 revenue and GAAP operating income guidance, and filed an omnibus shelf registration of up to about US$9.12 billion in various securities. The company also received FDA Priority Review and Breakthrough Therapy Designation for its TEVIMBRA and ZIIHERA combination in HER2-positive gastroesophageal adenocarcinoma, supported by...

Nuvation Bio (NUVB) has drawn fresh attention after reporting first quarter revenue of US$83.23 million and a profit of US$5.4 million, alongside new FDA and guideline milestones for its oncology drug IBTROZI. See our latest analysis for Nuvation Bio. The stock has been volatile, with a 1-day share price return of a 4.56% decline following a strong 7-day share price return of 8.09%. The year-to-date share price return of a 43.94% decline contrasts with a very large 1-year total shareholder...

SL Green Realty (SLG) is back in focus after its One Madison Avenue project received the 2026 Urban Land Institute Award for Excellence in Development and reached 100% leasing, alongside flagship peer asset One Vanderbilt. See our latest analysis for SL Green Realty. The award recognition comes as momentum in SL Green Realty’s stock has picked up, with a 6.77% 7 day share price return and a 20.55% 30 day share price return. The 1 year total shareholder return is a 14.13% loss, while the 3...